Liu J, Zuo L, Walpen S, Bernard L, et al. Efficacy and safety of sucroferric oxyhydroxide compared with sevelamer carbonate in Chinese dialysis patients with hyperphosphataemia: A randomised, open-label, multicentre, 12-week phase III study. Nephron 2023 Jul 20:1. doi: 10.1159/000531869.
PMID: 37473746